SCHEMBL17987665

SCHEMBL17987665

CCSc1nc(CC)cs1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
PKM P14618 1/20 0.37
MPI P34949 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
HTR1A P08908 3/20 0.34
HTR7 P34969 3/20 0.34
HTR2A P28223 2/20 0.34
CDK2 P24941 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
DRD2 P14416 1/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12313676 0.81 HTR1A (0.37) GAAALDH1A1PTGS1PTGS2HTR1A
SCHEMBL21505286 0.77 ALDH1A1 (0.44) GAAALDH1A1KDM4EMEN1KMT2A
SCHEMBL15948524 0.77
SCHEMBL11446028 0.76 PTGS1 (0.34) GAAPTGS1PTGS2HTR1AHTR7
SCHEMBL18758738 0.76 PTGS1 (0.34) GAAPTGS1PTGS2NPC1POLB
SCHEMBL11446049 0.75 PTGS1 (0.34) GAAPTGS1PTGS2
SCHEMBL20819199 0.71 HPGD (0.45) GAAALDH1A1PKMAPOBEC3GTDP1
SCHEMBL12964364 0.71 PLA2G4A (0.46) ALDH1A1KDM4ETDP1L3MBTL1NPC1
SCHEMBL10062532 0.70 RAB9A (0.48) GAAALDH1A1KDM4ETDP1L3MBTL1
SCHEMBL2256127 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695132-B2 Heteroaryl compounds and uses thereof CELGENE CAR LLC (BM) 2017-07-04 US disclosed
US-20160221966-A1 HETEROARYL COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2016-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221966-A1 HETEROARYL COMPOUNDS AND USES THEREOF ABCG2, CYP3A43, CYP3A5 GAA 172/4885ALDH1A1 684/4885KDM4E 3792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.